Zymeworks, Inc. (ZYME)
29.95
-1.10
(-3.54%)
USD |
NASDAQ |
Sep 03, 12:54
Zymeworks Cash and Short Term Investments (Quarterly) : 270.70M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 270.70M |
| March 31, 2026 | 364.73M |
| December 31, 2025 | 228.80M |
| September 30, 2025 | 251.93M |
| June 30, 2025 | 281.38M |
| March 31, 2025 | 265.29M |
| December 31, 2024 | 225.78M |
| September 30, 2024 | 297.20M |
| June 30, 2024 | 330.15M |
| March 31, 2024 | 345.05M |
| December 31, 2023 | 374.33M |
| September 30, 2023 | 295.41M |
| June 30, 2023 | 340.09M |
| March 31, 2023 | 340.79M |
| December 31, 2022 | 492.23M |
| September 30, 2022 | 166.24M |
| June 30, 2022 | 241.83M |
| March 31, 2022 | 300.53M |
| December 31, 2021 | 252.61M |
| Date | Value |
|---|---|
| September 30, 2021 | 307.76M |
| June 30, 2021 | 359.81M |
| March 31, 2021 | 411.47M |
| December 31, 2020 | 426.35M |
| September 30, 2020 | 471.86M |
| June 30, 2020 | 436.79M |
| March 31, 2020 | 487.66M |
| December 31, 2019 | 298.90M |
| September 30, 2019 | 335.10M |
| June 30, 2019 | 355.65M |
| March 31, 2019 | 180.31M |
| December 31, 2018 | 200.16M |
| September 30, 2018 | 150.00M |
| June 30, 2018 | 166.23M |
| March 31, 2018 | 70.03M |
| December 31, 2017 | 87.80M |
| September 30, 2017 | 49.09M |
| June 30, 2017 | 62.48M |
| March 31, 2017 | 26.79M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 387.66M |
| BridgeBio Pharma, Inc. | 720.71M |
| Aprea Therapeutics, Inc. | 41.23M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |